PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

Summary

The purpose of this First in Man study is to evaluate the safety and tolerability, as well as to explore efficacy of PeproStat, a new peptide based coagulant (haemostat), when used in patients undergoing open liver resection surgery.

Timeline

Start

2014-07

Primary completion

2015-09

Completion

2015-09

Drugs

Indications